Ondine Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '25 Nov 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	56	45	25	48	146	-
Market Cap Growth	-11.34%	76.13%	-47.42%	-67.13%	-	-
Enterprise Value	52	44	23	33	172	-
Last Close Price	0.17	0.11	-	-	-	-
PS Ratio	34.65	31.26	27.74	101.96	72.03	-
PB Ratio	105.16	9.31	16.01	5.59	6.24	-
P/TBV Ratio	105.16	9.31	16.01	5.59	6.24	-
EV/Sales Ratio	32.58	30.82	24.90	69.74	84.97	-
Debt / Equity Ratio	0.76	0.02	0.26	0.12	0.02	-1.04
Asset Turnover	0.35	0.22	0.11	0.03	0.14	-
Inventory Turnover	0.58	0.62	0.42	0.30	1.80	-
Quick Ratio	0.76	1.73	0.95	3.41	7.81	0.03
Current Ratio	0.97	2.05	1.36	3.87	8.54	0.05
Return on Equity (ROE)	-6414.76%	-426.20%	-209.95%	-93.81%	-	-
Return on Assets (ROA)	-235.98%	-130.98%	-82.98%	-46.25%	-59.55%	-
Return on Capital Employed (ROCE)	-2475.30%	-282.70%	-659.80%	-148.20%	-58.00%	47.90%
Earnings Yield	-31.30%	-29.82%	-43.18%	-29.78%	-27.07%	-
FCF Yield	-24.37%	-24.20%	-41.44%	-25.60%	-6.82%	-
Buyback Yield / Dilution	-68.94%	-39.31%	-1.30%	-144.34%	-12.69%	-761.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.